Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

217
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201220132014201520162017
Sales26 43126 50523 00624 18024 97025 739
Operating income (EBITDA)9 4158 8838 0457 3187 8738 397
Operating profit (EBIT)8 3308 0156 5946 0026 5377 031
Pre-Tax Profit (EBT)6 6926 6472 9686 2214 8175 134
Net income4 5655 6282 7564 3832 9533 301
EPS (PNC)91,511156,711365,973,4
Dividend per Share (PNC)74,078,080,090,881,882,1
Yield5,49%5,79%5,94%6,74%6,07%6,10%
Announcement Date02/06/2013
12:01pm
02/05/2014
12:00pm
02/04/2015
03:18pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201220132014201520162017
Debt14 03712 64514 37711 49612 35912 765
Finance------
Operating income (EBITDA)9 4158 8838 0457 3187 8738 397
Leverage
(Debt/EBITDA)
1,49x1,42x1,79x1,57x1,57x1,52x
Capital Expenditure1 0511 1881 1882 1431 5021 480
Book Value Per Share (BVPS)120 PNC146 PNC87,6 PNC112 PNC117 PNC106 PNC
Cash Flow per Share87,7 PNC149 PNC108 PNC90,2 PNC106 PNC123 PNC
Announcement Date02/06/2013
12:01pm
02/05/2014
12:00pm
02/04/2015
03:18pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 65 575 M GBP -
Entreprise Value (EV) 77 070 M GBP 77 933 M GBP
Valuation 2015e 2016e
PER (Price / EPS) 11,9x 20,4x
Capitalization / Revenue 2,71x 2,63x
EV / Revenue 3,19x 3,12x
EV / EBITDA 10,5x 9,90x
Yield (DPS / Price) 6,74% 6,07%
Price to book (Price / BVPS) 12,0x 11,5x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 24,8% 26,2%
operating Leverage (Delta EBIT / Delta Sales) - 2,73x
Net Margin (Net Profit / Revenue) 18,1% 11,8%
ROA (Net Profit / Asset) 13,4% 9,10%
ROE (Net Profit / Equities) 82,8% 88,6%
Rate of Dividend 80,5% 124%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   8,86% 6,01%
Cash Flow / Sales (Taux d'autofinancement) 18,2% 20,6%
Capital Intensity (Assets / Sales) 1,35x 1,30x
Financial Leverage (Net Debt / EBITDA) 1,57x 1,57x
Price Earning Ratio
EPS & Dividend